LOS ANGELES--(BUSINESS WIRE)-- Global Coalition for Adaptive Research (GCAR) today announced an update on the progress of GBM AGILE (Glioblastoma Adaptive Global Innovative Learning Environment - ...
SYDNEY, Dec. 11, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it's lead program, GDC-0084 ...
Lead Program for Contraceptive Patch Candidate AG200-15 Recently Announced Early Completion of Patient Enrollment in Pivotal, Phase 3 NEW CHOICE Study PRINCETON, N.J.--(BUSINESS WIRE)-- Agile ...
PRINCETON, N.J., Sept. 3 /PRNewswire/ -- Agile Therapeutics, Inc., announced today that it successfully completed two key clinical trials in the development of the company's new, innovative low-dose, ...
The MarketWatch News Department was not involved in the creation of this content. MCLEAN, Va., Nov. 25, 2025 /PRNewswire/ -- Agile Defense today announced the full integration of IntelliBridge, ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Do you introduce Agile the right way? If yes, then you know that it provides diverse ...
SYDNEY, Dec. 11, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to announce that it's lead program, GDC-0084 ...
MCLEAN, Va., Nov. 25, 2025 /PRNewswire/ -- Agile Defense today announced the full integration of IntelliBridge, completing a strategic transformation that positions the company to deliver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback